Renal Function Improvement in HBsAg Positive Kidney Transplantation Patients Under Telbivudine Treatment.

NCT02894554 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

19

Enrollment

OTHER

Sponsor class

Stopped clinical myalgia

Conditions

HBsAg-positive Renal Allograft Recipients

Interventions

DRUG: Telbivudine
DRUG: Lamivudine

Sponsor

National Taiwan University Hospital